The possible pathway responsible for these protective effects of AGE is related to a reduction in microglia activation in the cerebral cortex and hippocampus of Aβ-induced and transgenic AD animal models, with the consequent inhibition of IL-1β and inflammation [112,119,124]. Here, IL1B is linked to Alzheimer disease.